🔗 Permalink

Inventor profile of:

Joseph E. Payne

City:

Oceanside, California

Country:

United States

Published Applications:

Last publication date:

2020-06-25

Top Assignees for applications by Joseph E. Payne

The entities that hold a legal rights for patent applications filed by inventor Payne Joseph E.:

NITTO DENKO CORPORATION 20 Osaka, Japan
Merck Sharp Dohme Corp. 3 Rahway, NJ United States
KALYPSYS, INC. 2 San Diego, CA United States
Merck & Co., Inc. 1 Rahway, NJ United States
Arcturus Therapeutics, Inc. 1 San Diego, CA United States

Recent patent applications by Payne Joseph E.

Joseph E. Payne from Oceanside, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-06-25

US20200199064A1

Chemistry; metallurgy

Cationic lipids for therapeutic agent delivery formulations

#2 | 2020-03-19

US20200085957A1

Human necessities

Lipids for therapeutic agent delivery formulations

#3 | 2018-10-18

US20180297938A1

Chemistry; metallurgy

Compounds for targeting drug delivery and enhancing siRNA activity

#4 | 2018-07-26

US20180208547A1

Chemistry; metallurgy

Cationic lipids for therapeutic agent delivery formulations

#5 | 2017-06-22

US20170175115A1

Chemistry; metallurgy

Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier

#6 | 2017-03-23

US20170081663A1

Chemistry; metallurgy

Retinoid-lipid drug carrier

#7 | 2017-01-05

US20170001950A1

Chemistry; metallurgy

Compounds for targeting drug delivery and enhancing siRNA activity

#8 | 2017-01-05

US20170000893A1

Human necessities

Compounds for targeting drug delivery and enhancing siRNA activity

#9 | 2016-05-19

US20160137593A1

Chemistry; metallurgy

Cationic lipids for therapeutic agent delivery formulations

#10 | 2016-03-17

US20160074514A1

Human necessities

Lipids for therapeutic agent delivery formulations

#11 | 2016-01-21

US20160015656A2

Human necessities

COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE

#12 | 2015-05-21

US20150141678A1

Chemistry; metallurgy

Ionizable cationic lipid for RNA delivery

#13 | 2014-12-04

US20140356413A1

Human necessities

Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier

#14 | 2014-10-02

US20140294934A1

Human necessities

Cationic lipids for therapeutic agent delivery formulations

#15 | 2013-12-12

US20130330401A1

Human necessities

Lipids for therapeutic agent delivery formulations

#16 | 2013-08-15

US20130210744A1

Human necessities

TARGETING AGENT FOR CANCER CELL OR CANCER-ASSOCIATED FIBROBLAST

#17 | 2013-07-04

US20130171240A1

Human necessities

DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS

#18 | 2013-07-04

US20130171127A1

Human necessities

COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE

#19 | 2013-03-21

US20130071478A1

Chemistry; metallurgy

Retinoid-liposomes for enhancing modulation of HSP47 expression

#20 | 2013-03-21

US20130071467A1

Human necessities

Retinoid-liposomes for treating fibrosis

#21 | 2013-01-24

US20130022665A1

Chemistry; metallurgy

Cationic lipids for therapeutic agent delivery formulations

#22 | 2013-01-17

US20130017249A1

Chemistry; metallurgy

Compounds for targeting drug delivery and enhancing siRNA activity

#23 | 2012-11-15

US20120289696A1

Chemistry; metallurgy

Thiazolyl mGluR5 antagonists and methods for their use

#24 | 2011-09-22

US20110230526A1

Chemistry; metallurgy

Thiazolyl mGluR5 antagonists and methods for their use

#25 | 2009-08-13

US20090203903A1

Chemistry; metallurgy

Thiazolyl mglur5 antagonists and methods for their use

#26 | 2009-04-23

US20090105124A1

Chemistry; metallurgy

HETEROCYCLIC MODULATORS OF TGR5

#27 | 2008-06-12

US20080139558A1

Chemistry; metallurgy

QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS

#28 | 2008-06-05

US20080132488A1

Chemistry; metallurgy

Prodrugs of (2R)-2-propyloctanoic acid for the treatment of stroke

#29 | 2007-02-01

US20070027184A1

Chemistry; metallurgy

Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease

#30 | 2006-08-24

US20060189682A1

Chemistry; metallurgy

Water soluble prodrugs of COX-2 inhibitors

InventorID:

40372 ⎘